First Trust Advisors
ANIP icon

First Trust Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

First Trust Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.1M Sell
97,863
-1,884
-2% -$151K ﹤0.01% 1308
2026
Q1 		$7.67M Buy
99,747
+11,346
+13% +$886K 0.01% 1227
2025
Q4 		$6.98M Buy
88,401
+19,012
+27% +$1.65M 0.01% 1255
2025
Q3 		$6.36M Sell
69,389
-11,825
-15% -$964K ﹤0.01% 1270
2025
Q2 		$5.3M Buy
81,214
+45,613
+128% +$2.97M ﹤0.01% 1331
2025
Q1 		$2.38M Buy
35,601
+3,070
+9% +$183K ﹤0.01% 1707
2024
Q4 		$1.8M Sell
32,531
-4,876
-13% -$280K ﹤0.01% 1852
2024
Q3 		$2.23M Sell
37,407
-24,372
-39% -$1.49M ﹤0.01% 1739
2024
Q2 		$3.93M Buy
+61,779
New +$4.01M ﹤0.01% 1388
2020
Q1 		– Sell
-22,584
Closed -$1.39M – 2348
2019
Q4 		$1.39M Buy
+22,584
New +$1.5M ﹤0.01% 1735
2019
Q3 		– Sell
-15,392
Closed -$1.26M – 2390
2019
Q2 		$1.26M Buy
15,392
+270
+2% +$19.2K ﹤0.01% 1769
2019
Q1 		$1.07M Buy
15,122
+179
+1% +$10.5K ﹤0.01% 1836
2018
Q4 		$673K Buy
14,943
+2,378
+19% +$125K ﹤0.01% 2012
2018
Q3 		$710K Buy
+12,565
New +$769K ﹤0.01% 2062
2016
Q2 		– Sell
-17,964
Closed -$605K – 2274
2016
Q1 		$605K Sell
17,964
-7,382
-29% -$250K ﹤0.01% 1865
2015
Q4 		$1.14M Sell
25,346
-6,935
-21% -$299K ﹤0.01% 1683
2015
Q3 		$1.27M Sell
32,281
-23,337
-42% -$1.33M ﹤0.01% 1633
2015
Q2 		$3.45M Buy
+55,618
New +$3.31M 0.01% 1201

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Trust Advisors's ANIP Position: Q2 2026 in Review

First Trust Advisors reduced its ANI Pharmaceuticals (ANIP) stake by 1.9% in Q2 2026, selling an estimated $151K and leaving 97,863 shares worth $8.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1308.

First Trust Advisors first reported a position in ANIP in Q2 2015 and has held it in 18 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • First Trust Advisors held 97,863 shares of ANI Pharmaceuticals worth $8.1M as of Q2 2026.
  • First Trust Advisors sold 1,884 ANI Pharmaceuticals shares in Q2 2026, an estimated $151K.
  • ANI Pharmaceuticals made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #1308 holding.
  • First Trust Advisors first reported a position in ANI Pharmaceuticals in Q2 2015 and has held it in 18 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.